论文部分内容阅读
肺癌为当今世界最常见的恶性肿瘤之一,在男女常见的恶性肿瘤死亡中居首位,而且发病率在世界范围内呈上升趋势。依据组织病理特性,肺癌分为非小细胞肺癌(NSCLC)和小细胞肺癌(SCLC),其中NSCLC占约80%。多数肺癌患者就诊时已属晚期,需行全身化疗。目前其标准一线治疗是全身放化疗
Lung cancer is one of the most common malignant tumors in the world today. It ranks the first among the common malignant tumor deaths in men and women, and its incidence is on the rise in the world. According to histopathological features, lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), of which about 80% of NSCLC. The majority of patients with lung cancer is already in advanced stages of treatment, requiring systemic chemotherapy. At present, the standard first-line treatment is systemic radiotherapy and chemotherapy